Protocol Category
Fat Loss
Protocols combining lipolytic peptides, AMPK activators, and GLP-1 agonists for body composition and metabolic health.
Intermediate
Advanced Fat Loss Cutting Stack
A multi-mechanism peptide cutting protocol combining selective lipolysis, metabolic rate elevation, insulin sensitization, and GH-mediated fat oxidation for aggressive body recomposition.
Advanced Metabolic Fat Loss Stack
A multi-mechanism fat loss protocol combining GLP-1 agonism, targeted adipose lipolysis, AMPK activation, and mitochondrial biogenesis. Designed for significant, sustained fat loss with metabolic health improvements.
Body Recomposition: Fat Loss + Lean Mass
Simultaneously reduce body fat and build lean muscle using complementary GH axis peptides and targeted lipolytic compounds. The gold standard body recomposition stack.
Comprehensive Type 2 Diabetes & Metabolic Syndrome Stack
A multi-mechanism peptide protocol addressing the root causes of type 2 diabetes and metabolic syndrome: insulin resistance, visceral adiposity, hepatic glucose production, beta-cell dysfunction, and chronic metabolic inflammation.
GLP-1 Comprehensive Obesity & Metabolic Reset
Structured GLP-1 agonist protocol for significant weight loss using dose escalation from Semaglutide to Tirzepatide or Retatrutide. Combines gut hormone axis modulation with metabolic enhancers.
GLP-1 Metabolic & Fat Loss Stack
A synergistic fat loss and metabolic optimization stack combining a GLP-1 receptor agonist for appetite suppression with targeted fat-mobilization peptides and AMPK activators for maximum body recomposition.
Insulin Resistance & Metabolic Syndrome Reversal Protocol
Comprehensive metabolic peptide protocol targeting insulin resistance, visceral adiposity, mitochondrial dysfunction, and chronic inflammation underlying metabolic syndrome.
Metabolic Syndrome & Insulin Resistance Protocol
A protocol targeting the five components of metabolic syndrome — central obesity, hypertriglyceridemia, low HDL, hypertension, and insulin resistance — through GLP-1 receptor agonism, AMPK activation, mitochondrial enhancement, and adipose tissue remodeling.
Metabolic Syndrome & Insulin Resistance Reversal
Multi-mechanism protocol for reversing metabolic syndrome, insulin resistance, and visceral adiposity. Combines GLP-1 signaling with intracellular metabolic reprogramming peptides.
The Body Composition Stack
Designed for people on GLP-1 agonists (Semaglutide/Tirzepatide) who want to maximize fat loss while preserving lean muscle. Clinical data shows 30–40% of weight lost on GLP-1s alone comes from muscle — this stack corrects that.
Advanced
HIV Lipodystrophy & Visceral Fat Reduction Protocol
A clinically-validated protocol for HIV-associated lipodystrophy using Tesamorelin alongside complementary peptides to reduce visceral adiposity, improve metabolic parameters, and support immune function in HIV-positive individuals on antiretroviral therapy.
Medically Supervised Extreme Weight Loss Protocol
Maximum-intensity peptide protocol for significant obesity (BMI 35+) combining multiple lipolytic, appetite-suppressing, and metabolic-restoring mechanisms under medical supervision.
NAFLD & Metabolic Liver Disease Protocol
A comprehensive protocol targeting non-alcoholic fatty liver disease and metabolic-associated steatohepatitis (MASH) through GLP-1 receptor agonism, AMPK activation, and mitochondrial support to reduce hepatic fat and inflammation.
NAFLD & Metabolic Liver Disease Protocol
Hepatoprotective peptide protocol for non-alcoholic fatty liver disease targeting hepatic steatosis, inflammation, fibrosis prevention, and restoration of liver mitochondrial function.
Pre-Competition Body Recomposition & Peak Week Stack
A precision fat-loss protocol for competitive bodybuilders and physique athletes in the final 8–12 weeks before competition, targeting stubborn body fat while preserving muscle mass and enhancing vascularity.